The pcDNA3.1 plasmids encoding the SARS-CoV-2 S ectodomain (amino acids 1 to 1208) followed by a fold-on trimerization motif and tags (8×HisTag, StrepTag, and AviTag) and the RBD (amino acids 331 to 519), were kindly provided by Prof. Felix Rey (Structural Virology Research Unit, Institut Pasteur Paris) [5 (
link)]. The pETM11 expression vector encoding the His-tagged SARS-CoV-2 N protein was kindly provided by Dr. Nicolas Escriou (Laboratoire d’Innovation: Vaccins, Institut Pasteur Paris) [5 (
link),18 (
link),19 (
link)].
The trimeric S glycoprotein and its RBD fragment were produced by transient expression of exponentially growing
Expi293 suspension cells (Thermo Fisher Scientific, Waltham, MA) using
FectoPRO® transfection reagent (Polyplus) following the manufacturer’s guidelines. Recombinant proteins were purified by affinity chromatography using
Strep-Tactin®XT 4flow column (IBA lifesciences) according to the manufacturer’s instructions. The His-tagged SARS-CoV-2 N protein was bacterially expressed in E. coli BL21 (DE3) and purified as a soluble dimeric protein by affinity purification using a
Ni-NTA Protino column (Macherey Nagel). The eluates were analysed in 4–20% gradient precast protein gels (Nippon Genetics).
Sarrigeorgiou I., Moschandreou D., Dimitriadis A., Tsinti G., Sotiropoulou E., Ntoukaki E., Eliadis P., Backovic M., Labropoulou S., Escriou N., Pouliakis A., Giannopoulou G., Gaitanarou E., Lazaridis K., Mentis A., Mamalaki A., Grouzi E, & Lymberi P. (2022). Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers. PLOS ONE, 17(11), e0277827.